Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5520)
All Articles published online
|
May 7, 2011 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Díaz-Jiménez D, Núñez LE, Beltrán CJ, Candia E, Suazo C, Álvarez-Lobos M, González MJ, Hermoso MA, Quera R. Soluble ST2: A new and promising activity marker in ulcerative colitis. World J Gastroenterol 2011; 17(17): 2181-2190 [PMID: 21633527 DOI: 10.3748/wjg.v17.i17.2181] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i17/2181.htm |
| Number | Citing Articles |
| 1 |
Luca Pastorelli, Carlo De Salvo, Maurizio Vecchi, Theresa T. Pizarro. The Role of IL-33 in Gut Mucosal Inflammation. Mediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/608187
|
| 2 |
Meng Wang, Guannan Shen, Liangguo Xu, Xiaodong Liu, Jared M. Brown, Dechun Feng, Ruth Ann Ross, Bin Gao, Suthat Liangpunsakul, Cynthia Ju. IL-1 receptor like 1 protects against alcoholic liver injury by limiting NF-κB activation in hepatic macrophages. Journal of Hepatology 2018; 68(1): 109 doi: 10.1016/j.jhep.2017.08.023
|
| 3 |
Cheng Pei, Mark Barbour, Karen J. Fairlie‐Clarke, Debbie Allan, Rong Mu, Hui‐Rong Jiang. Emerging role of interleukin‐33 in autoimmune diseases. Immunology 2014; 141(1): 9 doi: 10.1111/imm.12174
|
| 4 |
Abdulraouf M. Ramadan, Etienne Daguindau, Jason C. Rech, Krishnapriya Chinnaswamy, Jilu Zhang, Greg L. Hura, Brad Griesenauer, Zachary Bolten, Aaron Robida, Martha Larsen, Jeanne A. Stuckey, Chao-Yie Yang, Sophie Paczesny. From proteomics to discovery of first-in-class ST2 inhibitors active in vivo. JCI Insight 2018; 3(14) doi: 10.1172/jci.insight.99208
|
| 5 |
Qing Zhao, Guangjie Chen. Role of IL-33 and Its Receptor in T Cell-Mediated Autoimmune Diseases. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/587376
|
| 6 |
Yi Fengming, Wu Jianbing. Biomarkers of Inflammatory Bowel Disease. Disease Markers 2014; 2014: 1 doi: 10.1155/2014/710915
|
| 7 |
Yi Wang, Chengwei He, Shuzi Xin, Xiaohui Liu, Sitian Zhang, Boya Qiao, Hongwei Shang, Lei Gao, Jingdong Xu. A Deep View of the Biological Property of Interleukin-33 and Its Dysfunction in the Gut. International Journal of Molecular Sciences 2023; 24(17): 13504 doi: 10.3390/ijms241713504
|
| 8 |
Benjamin Dieplinger, Thomas Mueller. Soluble ST2 in heart failure. Clinica Chimica Acta 2015; 443: 57 doi: 10.1016/j.cca.2014.09.021
|
| 9 |
Linqing Xie, Guichan Liao, Hongjie Chen, Muye Xia, Xuan Huang, Rong Fan, Jie Peng, Xiaoyong Zhang, Hongyan Liu. Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis B. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4261-3
|
| 10 |
Maciej Idzik, Jakub Poloczek, Bronisława Skrzep-Poloczek, Elżbieta Chełmecka, Jerzy Jochem, Dominika Stygar, Jolanta Czuczejko. General Rehabilitation Program after Knee or Hip Replacement Significantly Influences Erythrocytes Oxidative Stress Markers and Serum ST2 Levels. Oxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/1358858
|
| 11 |
Jiarui Mi, Xia Wu, Xiaoyin Bai, Yang Yang, Hong Yang. ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study. Clinical and Translational Science 2023; 16(2): 236 doi: 10.1111/cts.13442
|
| 12 |
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scandinavian Journal of Gastroenterology 2022; 57(5): 513 doi: 10.1080/00365521.2021.2022193
|
| 13 |
Jingyun Xu, Lijia Wu, Pengcheng Yu, Yichun Sun, Yixin Lu. Effect of T. spiralis Serine protease inhibitors on TNBS-induced experimental colitis mediated by Macrophages. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60155-7
|
| 14 |
Jiayun Shen, Qing Shang, Chun-Kwok Wong, Edmund K. Li, Shang Wang, Rui-Jie Li, Ka-Lai Lee, Ying-Ying Leung, King-Yee Ying, Cheuk-Wan Yim, Emily W. Kun, Moon-Ho Leung, Martin Li, Tena K. Li, Tracy Y. Zhu, Shui-Lian Yu, Woon-Pang Kuan, Cheuk-Man Yu, Lai-Shan Tam. IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study. Seminars in Arthritis and Rheumatism 2015; 45(1): 18 doi: 10.1016/j.semarthrit.2015.02.001
|
| 15 |
C.P. Peters, J.M. Mjösberg, J.H. Bernink, H. Spits. Innate lymphoid cells in inflammatory bowel diseases. Immunology Letters 2016; 172: 124 doi: 10.1016/j.imlet.2015.10.004
|
| 16 |
Abdulraouf M. Ramadan, Etienne Daguindau, Jason C. Rech, Krishnapriya Chinnaswamy, Jilu Zhang, Brad Griesenauer, Zachary Bolten, Aaron Robida, Martha Larsen, Jeanne A. Stuckey, Chao-Yie Yang, Sophie Paczesny. Inhibition of Biomarker ST2 by Small Molecules Improves Survival in Allogeneic Hematopoietic Cell Transplantation. SSRN Electronic Journal 2018; doi: 10.2139/ssrn.3155805
|
| 17 |
Fernando Magro, Susana Lopes, Marco Silva, Rosa Coelho, Francisco Portela, Diogo Branquinho, Luís Correia, Samuel Fernandes, Marília Cravo, Paulo Caldeira, Helena Tavares de Sousa, Marta Patita, Paula Lago, Jaime Ramos, Joana Afonso, Isabel Redondo, Patrícia Machado, George Philip, Joanne Lopes, Fátima Carneiro. Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab. Therapeutic Advances in Gastroenterology 2019; 12: 175628481986914 doi: 10.1177/1756284819869141
|
| 18 |
Geethani Bandara, Michael A. Beaven, Ana Olivera, Alasdair M. Gilfillan, Dean D. Metcalfe. Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33. European Journal of Immunology 2015; 45(11): 3034 doi: 10.1002/eji.201545501
|
| 19 |
Chao-Yie Yang. Comparative Analyses of the Conformational Dynamics Between the Soluble and Membrane-Bound Cytokine Receptors. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-64034-z
|
| 20 |
Mohammad-Ali Jenabian, Mohamed El-Far, Kishanda Vyboh, Ido Kema, Cecilia T. Costiniuk, Rejean Thomas, Jean-Guy Baril, Roger LeBlanc, Cynthia Kanagaratham, Danuta Radzioch, Ossama Allam, Ali Ahmad, Bertrand Lebouché, Cécile Tremblay, Petronela Ancuta, Jean-Pierre Routy. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection. Journal of Infectious Diseases 2015; 212(3): 355 doi: 10.1093/infdis/jiv037
|
| 21 |
P. Kourkoulis, C. Kapizioni, G. Michalopoulos, N.P. Andreou, I. Papaconstantinou, G. Karamanolis, M. Gazouli. Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis. European Journal of Gastroenterology & Hepatology 2019; 31(10): 1173 doi: 10.1097/MEG.0000000000001490
|
| 22 |
Thomas Mueller, Allan S. Jaffe. Soluble ST2—Analytical Considerations. The American Journal of Cardiology 2015; 115(7): 8B doi: 10.1016/j.amjcard.2015.01.035
|
| 23 |
Brad Griesenauer, Sophie Paczesny. The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00475
|
| 24 |
Renata D’Incà, Giulia Sturniolo. Biomarkers in IBD: What to Utilize for the Diagnosis?. Diagnostics 2023; 13(18): 2931 doi: 10.3390/diagnostics13182931
|
| 25 |
Kaden L. Nystuen, Shannon M. McNamee, Monica Akula, Kristina M. Holton, Margaret M. DeAngelis, Neena B. Haider. Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments. Bioengineering 2024; 11(1): 45 doi: 10.3390/bioengineering11010045
|
| 26 |
Gökcan Öztürk, Deniz Bayrakoğlu, Şule Haskoloğlu, Kübra Baskın, Nazlı Deveci, Elif İnce, Talia İleri, Hasan Çakmaklı, Mehmet Ertem, Figen Doğu. ST2 and Reg3α: Can they predict aGvHD, steroid refractoriness and transplant-related mortality in pediatric patients after HSCT?. Hematology, Transfusion and Cell Therapy 2024; doi: 10.1016/j.htct.2024.02.026
|
| 27 |
Jilu Zhang, Abdulraouf M. Ramadan, Brad Griesenauer, Wei Li, Matthew J. Turner, Chen Liu, Reuben Kapur, Helmut Hanenberg, Bruce R. Blazar, Isao Tawara, Sophie Paczesny. ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease. Science Translational Medicine 2015; 7(308) doi: 10.1126/scitranslmed.aab0166
|
| 28 |
Weiwei Jiang, Xuhang Li. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy. Molecular Diagnosis & Therapy 2015; 19(3): 141 doi: 10.1007/s40291-015-0142-7
|
| 29 |
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer. Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 2020; 10(6): 367 doi: 10.3390/diagnostics10060367
|
| 30 |
Salih Boga, Huseyin Alkim, Ali Riza Koksal, Ayse Aysim Ozagari, Mehmet Bayram, Sebnem Tekin Neijmann, Ilker Sen, Canan Alkim. Serum St2 in Inflammatory Bowel Disease: A Potential Biomarker for Disease Activity. Journal of Investigative Medicine 2016; 64(5): 1016 doi: 10.1136/jim-2016-000062
|
| 31 |
Thomas Mueller, Benjamin Dieplinger. The Presage®ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2. Expert Review of Molecular Diagnostics 2013; 13(1): 13 doi: 10.1586/erm.12.128
|
| 32 |
Florent Artru, Mohamed Bou Saleh, François Maggiotto, Guillaume Lassailly, Massih Ningarhari, Julie Demaret, Line-Carolle Ntandja-Wandji, Jean-Paul Pais de Barros, Julien Labreuche, Elodie Drumez, Doumet Georges Helou, Sébastien Dharancy, Emilie Gantier, Axel Périanin, Sylvie Chollet-Martin, Ramon Bataller, Philippe Mathurin, Laurent Dubuquoy, Alexandre Louvet. IL-33/ST2 pathway regulates neutrophil migration and predicts outcome in patients with severe alcoholic hepatitis. Journal of Hepatology 2020; 72(6): 1052 doi: 10.1016/j.jhep.2019.12.017
|
| 33 |
David Díaz-Jiménez, Lucía Núñez, Marjorie De la Fuente, Karen Dubois-Camacho, Hugo Sepúlveda, Martín Montecino, Alejandro Torres-Riquelme, Paulina García-González, Jonás Chnaiderman, Anna Vossenkamper, Thomas T. MacDonald, Daniela Simian, María-Julieta González, John A. Cidlowski, Rodrigo Quera, Marcela A. Hermoso. A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10465-0
|
| 34 |
Aurora Holgado, Harald Braun, Elien Van Nuffel, Sammy Detry, Martijn J. Schuijs, Kim Deswarte, Karl Vergote, Mira Haegman, Griet Baudelet, Jurgen Haustraete, Hamida Hammad, Bart N. Lambrecht, Savvas N. Savvides, Inna S. Afonina, Rudi Beyaert. IL-33trap is a novel IL-33–neutralizing biologic that inhibits allergic airway inflammation. Journal of Allergy and Clinical Immunology 2019; 144(1): 204 doi: 10.1016/j.jaci.2019.02.028
|
| 35 |
Aysan Moeinafshar, Niloufar Yazdanpanah, Nima Rezaei. Diagnostic biomarkers of dilated cardiomyopathy. Immunobiology 2021; 226(6): 152153 doi: 10.1016/j.imbio.2021.152153
|
| 36 |
Chris Schiering, Thomas Krausgruber, Agnieszka Chomka, Anja Fröhlich, Krista Adelmann, Elizabeth A. Wohlfert, Johanna Pott, Thibault Griseri, Julia Bollrath, Ahmed N. Hegazy, Oliver J. Harrison, Benjamin M. J. Owens, Max Löhning, Yasmine Belkaid, Padraic G. Fallon, Fiona Powrie. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014; 513(7519): 564 doi: 10.1038/nature13577
|
| 37 |
Ying Xiao, Don W. Powell, Xiaowei Liu, Qingjie Li. Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2023; 325(2): R193 doi: 10.1152/ajpregu.00300.2022
|
| 38 |
Cristina Sastre, Matthew B. Bevers, W. Taylor Kimberly. Role of Interleukin-1 Receptor-Like 1 (ST2) in Cerebrovascular Disease. Neurocritical Care 2021; 35(3): 887 doi: 10.1007/s12028-021-01284-3
|
| 39 |
Hiroshi Takeyama, Tsunekazu Mizushima, Hideki Iijima, Shinzaki Shinichiro, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Ichiro Takemasa, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori. Platelet Activation Markers Are Associated with Crohn’s Disease Activity in Patients with Low C-Reactive Protein. Digestive Diseases and Sciences 2015; 60(11): 3418 doi: 10.1007/s10620-015-3745-2
|
| 40 |
David Díaz-Jiménez, Marjorie De la Fuente, Karen Dubois-Camacho, Glauben Landskron, Janitza Fuentes, Tamara Pérez, María Julieta González, Daniela Simian, Marcela A. Hermoso, Rodrigo Quera. Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0520-6
|
| 41 |
Marina García-Miguel, M. Julieta González, Rodrigo Quera, Marcela A. Hermoso. Innate Immunity Modulation by the IL-33/ST2 System in Intestinal Mucosa. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/142492
|
| 42 |
Enzo Candia, David Díaz-Jiménez, Patricia Langjahr, Lucía E. Núñez, Marjorie de la Fuente, Nancy Farfán, Francisco López-Kostner, Mario Abedrapo, Manuel Alvarez-Lobos, George Pinedo, Caroll J. Beltrán, Carlos González, María-Julieta González, Rodrigo Quera, Marcela A. Hermoso. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients. Immunobiology 2012; 217(6): 634 doi: 10.1016/j.imbio.2011.10.023
|
| 43 |
Seung Min Jung, Jaeseon Lee, Seung Ye Baek, Jae Ho Lee, Jennifer Lee, Kyung-Su Park, Sung-Hwan Park, Ho-Youn Kim, Seung-Ki Kwok. The Interleukin 33/ST2 Axis in Patients with Primary Sjögren Syndrome: Expression in Serum and Salivary Glands, and the Clinical Association. The Journal of Rheumatology 2015; 42(2): 264 doi: 10.3899/jrheum.140234
|
| 44 |
Bruce E. Sands. Biomarkers of Inflammation in Inflammatory Bowel Disease. Gastroenterology 2015; 149(5): 1275 doi: 10.1053/j.gastro.2015.07.003
|
| 45 |
Radislav Nakov. New markers in ulcerative colitis. Clinica Chimica Acta 2019; 497: 141 doi: 10.1016/j.cca.2019.07.033
|
| 46 |
Xinrui Yuan, Krishnapriya Chinnaswamy, Jeanne A. Stuckey, Chao-Yie Yang. Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 Binding. The Journal of Physical Chemistry B 2022; 126(12): 2394 doi: 10.1021/acs.jpcb.2c00341
|
| 47 |
Evgenija Homsak, Damien Gruson. Soluble ST2: A complex and diverse role in several diseases. Clinica Chimica Acta 2020; 507: 75 doi: 10.1016/j.cca.2020.04.011
|